Ge Healthcare Technologies Inc (GEHC) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ge Healthcare Technologies Inc   (NASDAQ: GEHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Ge Healthcare Technologies Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ge Healthcare Technologies Inc's ROI in the first quarter of 2026?
Ge Healthcare Technologies Inc achieved a return on average invested assets (ROI) of 7.34 % in its first quarter of 2026, which is below Ge Healthcare Technologies Inc's average return on investment, which stands at 7.74%.

ROI decreased relative to the period ending Dec 31 2025, due to the decline in net income.

Within the Healthcare sector 138 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 857 to 1166.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 10.35 % 9.88 % 5.61 % 5.05 % 1.52 %
Y / Y Net Income Change TTM -12.13 % 5.07 % 74.33 % 181.29 % 479.9 %
Investment (TTM) in Millions 28,340 27,608 26,054 25,753 25,506
Return On Investment (TTM) 7.34 % 8.21 % 9.08 % 9.27 % 9.22 %
GEHC's Overall Ranking # 1166 # 857 # 816 # 707 # 268
Seq. Investment Change TTM 2.7 % 4.1 % 0.93 % 2.27 % 2.26 %
Seq. Net Income Change TTM -8.22 % -5.9 % -1.12 % 2.89 % 9.76 %
Net Income (TTM) in Millions 1,977 2,154 2,289 2,315 2,250

GEHC Company Profile >> Back to GEHC Roi Comparisons >> See Annual GEHC Return On Investment



Return On Investment GEHC's Ranking
Within: No.
Industry # 6
Sector # 139
Overall # 1166

Return On Investment Statistics
High Average Low
9.23 %
7.74 %
6.28 %
(Jun 30 2025)   (Mar 31 2023)







Financial Statements
Ge Healthcare Technologies Inc's I. Quarter Investments $ 28,340 Millions GEHC's Balance sheet
Ge Healthcare Technologies Inc's I. Quarter Income $ 411 Millions Quarterly GEHC's Income Statement
GEHC's Income by Division See GEHC's Income by Division


GEHC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023

Total Investments in Millions 27,608 23,480 23,405 0 0
Y / Y Investment Growth 17.58 % 0.32 % - - -
Net Income in Millions 2,154 2,050 1,614 0 0
Y / Y Net Income Growth 5.07 % 27.01 % - - -
Annual Return On Investment 7.8 % 8.73 % 6.9 % - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 7.8 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GEHC's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GEHC's Competitors
Subscribers only: Roi for Ge Healthcare Technologies Inc's Suppliers
Subscribers only: Return On Investment for GEHC's Customers

Other Ratios
GEHC's Roa GEHC's Inventory Turnover Ratio GEHC's Growth Rates GEHC's Dividend Statistics
GEHC's Profitability Ratios GEHC's Asset Turnover Ratio GEHC's Dividend Growth
GEHC's Roe GEHC's Valuation Ratios GEHC's Financial Strength Ratios GEHC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Soleno Therapeutics Inc  19.51 %
Krystal Biotech Inc   19.07 %
Puma Biotechnology Inc   18.83 %
United Therapeutics Corporation  18.64 %
Hca Healthcare Inc   18.54 %
Chemed Corporation  18.36 %
Apellis Pharmaceuticals Inc   17.94 %
Neurocrine Biosciences Inc   17.65 %
Halozyme Therapeutics Inc   17.53 %
Transmedics Group Inc   17.09 %
Inspire Medical Systems inc   16.60 %
Aveanna Healthcare Holdings Inc   16.38 %
Intuitive Surgical Inc   16.36 %
Alnylam Pharmaceuticals Inc   16.15 %
Strata Critical Medical Inc   16.15 %
Standard Biotools Inc   15.94 %
Profound Medical Corp   15.18 %
West Pharmaceutical Services Inc   14.67 %
Embecta Corp   14.58 %
Lantheus Holdings Inc   14.24 %
Lifevantage Corp  13.20 %
Harmony Biosciences Holdings inc   13.07 %
Sbc Medical Group Holdings Incorporated  13.05 %
Johnson and Johnson  13.01 %
Progyny Inc   12.72 %
Universal Health Services Inc   12.68 %
Insulet Corporation  12.55 %
Encompass Health Corporation  12.43 %
Globus Medical Inc   12.37 %
Regeneron Pharmaceuticals Inc   12.19 %

Date modified: 2026-09-08T15:11:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.